AI-generated summary
This review examines photobiomodulation therapy for traumatic spinal cord injury and the authors report that rodent studies across multiple parameters have shown improved functional recovery. The authors state that clinical translation still requires work on dosing, efficacy and safety in large animal models and humans, and on clinical-grade delivery systems.
- Who or what was studied
- Traumatic spinal cord injury; evidence described is primarily from rodent models
- Limits stated in the abstract
- The abstract states that much of the evidence comes from rodent models and that efficacy and safety in large animals and humans remain to be established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Clinical-grade, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.